Document is current

Article History

Accepted: 30 November 2021

First Online: 9 March 2022

Declarations

:

: Maria João de Sousa: Honoraria payment from Servier for public speaking;Lorenzo Gervaso declare no conflict of interest; Monica Isabel Meneses-Medina: Grant from European School of Oncology and Fundación para la Salud y Educación Dr. Salvador Zubirán A.C., support for attending ESMO 2021 meeting from Lilly, honoraria payment from MSD and from Roche for public speaking. Francesca Spada: Consulting or advisory role: Ipsen, Novartis, Advanced Accelerator Applications; Speakers' Bureau: Ipsen, Novartis, S.O.S., Advanced Accelerator Applications Travel; Accommodations, Expenses: Ipsen, Novartis, Advanced Accelerator Applications; Member of the Neuroendocrine and Endocrine Faculty of ESMO Omar Abdel-Rahman: Personal financial interests: Advisory board, public speaking: Ipsen, Eisai, Roche, Lilly, Bayer; Institutional financial interests: Clinical trials (P.I.): Ipsen. Nicola Fazio: Personal financial interests: Advisory board, public speaking: Novartis, Ipsen, Pfizer, Merck, Advanced Accelerator Applications, MSD, Sanofi- Aventis; Institutional financial interests: Clinical trials (P.I., Steering committee): Novartis, Ipsen, Merck Serono, MSD, Pharmacyclics, Incyte, Halozyme, Roche, Astellas, Pfizer, FivePrime, BeiGene; Research funds: Ipsen, Merck, AAA.

: This article does not contain any studies with human or animal subjects performed by any of the authors.